One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus

Transplantation Proceedings

Volumn 38, Issue 1, 2006, Pages 81-85

  Chamienia, A ^a   Biedunkiewicz, B ^a   Krol E ^a   Debska Slizien A ^a   Rutkowski, B ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; CYCLOSPORIN A; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TSUKUBAENOLIDE;

ADULT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

ADULT; CREATININE; CYCLOSPORINE; EMULSIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644544726     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.081     Document Type: Conference Paper

References (23)

1. W. Fiebiger, C. Mitterbauer, R. Oberbauer Health-related quality of life outcomes after kidney transplantation Health and Quality of Life Outcomes 2004 2
2. I.H. Klein, A. Abrahams, T. van Ede Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 73 2002 732
3. Y.M. Woo, A.G. Jardine, A.F. Clark Early graft function and patient survival following cadaveric renal transplantation Kidney Int 55 1999 692
4. G. Ligtenberg, R.J. Hene, P.J. Blankestijn Cardiovascular risk factors in renal transplant patients cyclosporin A versus tacrolimus J Am Soc Nephrol 12 2001 368
5. M.R. Weir, J.C. Fink Risk for posttransplant diabetes mellitus with current immunosuppressive medications Am J Kidney Dis 34 1999 1
6. A. Mayer Chronic rejection and graft half-life five-year follow- up of the European tacrolimus multicenter renal study Transplant Proc 34 2002 1491
7. F. Vincenti, S.C. Jensik, R.S. Filo A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation evidence for improved allograft survival at five years Transplantation 73 2002 775
8. W.A. Jurewicz Tacrolimus versus ciclosporin immunosuppression long-term outcome in renal transplantation Nephrol Dial Transplant 18 suppl 1 2003 i7
9. B. Kaplan, J.D. Schold, H.U. Meier-Kriesche Long-term graft survival with Neoral and tacrolimus a paired kidney analysis J Am Soc Nephrol 14 2003 2980
10. B.K. Kramer, C. Zulke, M.C. Kammerl Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation Am J Transplant 3 2003 982
11. H.U. Meier-Kriesche, B. Kaplan Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune Am J Transplant 2 2002 100
12. G.A. Knoll, R.C. Bell Tacrolimus versus cyclosporin for immunosuppression in renal transplantation meta-analysis of randomised trials BMJ 318 1999 1104
13. A. Lindholm, D. Albrechtsen, L. Frodin Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia Transplantation 60 1995 451
14. M. Pascual, T. Theruvath, T. Kawai Strategies to improve long-term outcomes after renal transplantation N Engl J Med 346 2002 580
15. T.R. McCune, L.R. Thacker II, T.G. Peters Effects of tacrolimus on hyperlipidemia after successful renal transplantation a Southeastern Organ Procurement Foundation multicenter clinical study Transplantation 65 1998 87
16. S. Hariharan, M.A. McBride, W.S. Cherikh Post-transplant renal function in the first year predicts long-term kidney transplant survival Kidney Int 62 2002 311
17. J.D. Pirsch, J. Miller, M.H. Deierhoi A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation FK506 Kidney Transplant Study Group Transplantation 63 1997 977
18. K. Baboolal, G.A. Jones, A. Janezic Molecular and structural consequences of early renal allograft injury Kidney Int 61 2002 686
19. O.A. Rayyes, A. Wallmark, C.H. Floren Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25% Hepatology 24 1996 613
20. M.A. Artz, J.M. Boots, G. Ligtenberg Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus J Am Soc Nephrol 14 2003 1880
21. J.M.M. Boots, E.M. van Duijnhoven, M.H.L. Christiaans Glucose metabolism in renal transplant recipients on tacrolimus the effect of steroid withdrawal and tacrolimus trough level reduction J Am Soc Nephrol 13 2002 221
22. E.M. van Duijnhoven, M.H.L. Christiaans, J.M.M. Boots Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression J Am Soc Nephrol 13 2002 213
23. Z.A. Massy, C. Guijarro, M.R. Wiederkehr Chronic renal allograft rejection Immunologic and nonimmunologic risk factors Kidney Int 49 1996 518